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Economic analysis provides an additional tool to assist legislators and
public officials in the decision making process with regard to rabies
control programmes.
This manuscript provides a framework for economic assessment of rabies
control programmes and outlines multiple techniques for estimating
benefits when uncertainty exists.
Study findings provide support for large scale rabies control programmes
and the analysis provides an explanation of intangible benefits that should
additionally be considered.
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Summary
Ontario initiated a red fox (Vulpes vulpes) oral rabies vaccination (ORV) programme in 1989. This study utilized a benefit-cost analysis to determine if this
ORV programme was economically worthwhile. Between 1979 and 1989, prior
to ORV baiting, the average annual human post-exposure treatments, positive
red fox rabies diagnostic tests and indemnity payments for livestock lost to
rabies were 2248, 1861 and $246 809, respectively. After baiting, from 1990 to
2000, a 35%, 66% and 41% decrease in post-exposure treatments, animal rabies
tests and indemnity payments was observed, respectively. These reductions were
viewed as benefits of the ORV programme, whereas total costs were those associated with ORV baiting. Multiple techniques were used to estimate four different benefit streams and the total estimated benefits ranged from $35 486 316
to $98 413 217. The annual mean ORV programme cost was $6 447 720, with
total programme costs of $77 372 637. The average benefit-cost ratios over the
analysis period were .49, 1.06, 1.27 and 1.36, indicating overall programme
efficiency in three of the four conservative scenarios.

Introduction
In 1979, the Ontario Ministry of Natural Resources
(OMNR) embarked on an ambitious plan to control
rabies in the province of Ontario. In previous years,
Ontario had the dubious distinction of being the rabies
capital of North America because of the consistently large
numbers of human post-exposure treatment (PET) and
domestic and companion animal rabies cases. Reasoning
that the large numbers of cases came from Ontario wildlife, scientists working on rabies with the OMNR felt that
wildlife vaccination was the most direct and cost-efficient

way of reducing the effects of rabies in the Province
(MacInnes et al., 2001; Nunan et al., 2002).
Work began on the development of an attractant and
vaccine package that would withstand aerial delivery,
and an aerial delivery system (Bachmann et al., 1990;
MacInnes et al., 2001). In 1989, all aspects of the programme were ready and preliminary baiting in eastern
Ontario was begun. Bolstered by initial successes, the
programme was quickly increased to encompass the
entire rabies endemic area of the province, which
included all of southern Ontario as well as large urban
areas such as greater metro Toronto (Rosatte et al.,
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2007). At its height, the programme delivered more than
2 million baits and had an annual budget of almost $7
million (Table 1).
A comprehensive analysis of PETs, animal rabies tests
and indemnity payments for rabies-caused deaths of livestock in Ontario Province between 1989 and 2000 was
performed to better quantify the OMNR ORV programme (Nunan et al., 2002). Numerous economic data
have been used to characterize rabies-related impacts
(Meltzer and Rupprecht, 1998a,b). Several ex post studies
have quantified both rabies- and ORV-incurred costs
(Uhaa et al., 1992; Kreindel et al., 1998; Chang et al.,
2002; Foroutan et al., 2002; Nunan et al., 2002; Shwiff
et al., 2007, 2008; ) and additionally, two studies have
modelled ORV economics using benefit-cost analysis
(BCA) (Meltzer, 1996; Kemere et al., 2002). Costs of PETs
have been used routinely as the single greatest rabiesinduced expense to society (Meltzer and Rupprecht,
1998a; b). More recently, an ex post analysis of 5 years
of rabies–related records for clinics and public health
agencies in San Luis Obispo and Santa Barbara counties
California estimated both direct and indirect costs of
rabies (Shwiff et al., 2007).
We describe a comprehensive BCA of the OMNR
ORV programme for Arctic variant rabies in the
Ontario province from 1989 to 2000. Initially, an analysis of variance (anova) examines the variables pre- and
post-ORV to determine if there is a significant difference between the average level of PETs, animal rabies
tests and indemnity payments before and after the initiation of the ORV programme (pre- versus post-ORV).
It further provides an economic assessment of empirical
costs and potential savings to the province associated with the ORV programme, as well as a sensitivity
analysis to broaden the scope of the results of this
analysis.
Table 1. Total annual budget for the Ontario oral rabies vaccination
programme in 2006 CAD (1989–2000)
Year

ORV programme costs

1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
Total

$4 955 110
$13 403 946
$8 918 718
$4 808 712
$3 732 025
$4 943 335
$6 165 058
$6 162 402
$6 190 792
$5 198 597
$5 597 983
$7 295 960
$77 372 637
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Materials and Methods
We gathered data on PET, animal rabies tests (AT) and
indemnification (INDEM) from several sources (Figs 1–3)
(Nunan et al., 2002). Data were available on the number
of human PETs from 1959 to 2000, animals that tested
positive from 1960 to 2000 and indemnity payments from
1979 to 2000. All of the data available for each variable
were used when calculating the trend in the variables;
however, when calculating the average cases during the
pre- and post-ORV time periods, only data were used
from 1979 to 1989 and 1990 to 2000, respectively. Information on costs of human PETs was unavailable, and
therefore was estimated. The annual cost of the Rabies
Indemnification Programme over the study period was
obtained from the Ontario Ministry of Agriculture, Food
and Rural Affairs. The Rabies Indemnification Programme provides reimbursements to ranchers whose livestock were lost to the disease. Information on the cost of
all OMNR Rabies Research Unit activities, including all
information regarding bait and delivery system development, including actual bait dropping, were obtained
directly from the OMNR, Rabies Research Unit (Nunan
et al., 2002).
The PET and AT time series were tested for a unit root
and both were determined to be stationary. Both series
have autocorrelation functions (ACF) that decay rapidly
with t-values falling below the practical warning level of
1.6 after lag 2 for PET, and lag 3 for AT and INDEM.
Therefore, forecasting methods were chosen that would
be applicable to stationary time series. The data exhibit
no seasonality with ACF t-values less than 1.3, the practical warning level for seasonal lengths. PET and AT both
offered sufficient pre-intervention data justifying the
application of standard stationary, non-seasonal time
series techniques.
A cursory inspection of the data suggests that on average the pre-intervention period has a higher mean than
the post-period. A quick way to determine this is to use
an anova to test the pre- versus post-levels of PET, AT
and INDEM. A means equality test was performed based
on a single-factor, between-subjects anova. If the subgroups have the same mean, then the variability between
the sample means (between groups) should be the same
as the variability within any subgroup (within group).
This type of analysis determines if the means of two
groups differ. Expectations regarding the pre- versus
post-ORV means of PET, AT and INDEM were that as
a result of the OMNR ORV programme, the means in
the post-ORV years were significantly lower than in the
pre-ORV years. All data were analysed using the
eviews6 software program (Quantitative Micro Software,
1994).
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Fig. 1. Number of post-exposure treatments administered in Canada versus the number predicted in the absence of oral rabies vaccine baiting
(1959–2000).
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Fig. 2. Number of animals testing positive for rabies in Canada versus the number predicted in the absence of oral rabies vaccine baiting (1960–
2000).

Benefit-cost analysis is a common tool used by economists to evaluate government programmes and determine
the efficiency of management efforts. In this BCA, the
monetary benefits and costs of the OMNR ORV programme actions were identified and compared. Benefitcost analysis is most often used when there are non-marketed goods and services to value, such as environmental
goods. The service of protecting human health and safety
ª 2010 Blackwell Verlag GmbH • Zoonoses Public Health. 58 (2011) 169–177

from red fox rabies involves non-market items. To measure such values, a number of concepts and measurement
techniques have been developed (Zerbe and Dively, 1994).
One accepted methodology to value non-market services is the damage-avoided method (King and Mazzotta,
2006). The damage-avoided method uses the value of
human health and safety resources protected, in this case
PETs, AT and INDEM, as a measure of the benefits
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provided by the OMNR ORV programme (Boardman et
al., 1996). Here, it was posited that the ORV programme
contained and prevented the spread of this variant
through the rest of the province and potentially to other
parts of Canada. Conversely, if the OMNR were to cease
the ORV programme, cases of the disease would likely
increase and spread throughout the Province.
Benefit-cost analyses are typically performed prior to
the actual start of the programme under study. As this
was a retrospective study, the actual programme commencement preceded the BCA. Commonly, economic valuation of cost is more easily accomplished than valuation
of benefit. This was true in the case of the OMNR ORV
Programme in Ontario, as the benefits are enjoyed by
many (the entire population of the province) and the
costs are borne by only a few (the government). Because
costs of all aspects of the ORV Programme were borne by
the government, we determined that all benefits of the
ORV Programme should accrue to the provincial budget
as well, reducing the amount of data and the number of
information sources that were necessary.
Benefits were largely driven by the expected savings
from reduced costs associated with the burden of the disease. Benefits were the savings associated with the reduced
number of human exposures, reduced number of animal
tests and fewer indemnity payments. Costs were incurred
for baits, air time, fuel, ground baiting, surveillance, project planning and evaluation.
Baiting began in 1989 and this year was included in
the pre-ORV calculation of the average number of cases
of PET, AT and INDEM because this initial year of
baiting was unique. The vaccine did not actively protect
the fox population in eastern Ontario until late in the
year. Therefore, the pre-ORV time period includes
1979–1989 and the post-ORV period was from 1990 to
2000 when calculating the average number of cases for
each variable. We constructed our BCA in terms of
four different forecasting techniques to provide a range
of estimates of future cases of PET, AT and indemnity
payments, to attempt to reduce uncertainty about the
magnitude of the impact we predict and the values we
assign to them.
For this study, total benefits (TB) of the ORV programme were equal to the savings resulting from the
ORV programme operation since 1989. Data indicate that
as a result of initiation, PETs, AT and INDEM decreased.
These decreases were seen as the benefits of the OMNR
ORV programme.
The annual TB equal the PET costs, AT costs and
INDEM saved,
y

y

y

TBy ¼ PETsaved þ ATsaved þ INDEMsaved ;
where y represents the year.
172

ð1Þ

Three steps were necessary to determine the savings
that resulted from the operation of the OMNR ORV programme. First, it was necessary to predict the number of
cases that would have existed in the absence of the ORV
programme, based on the data prior to the initiation. Second, the annual cost of each variable was determined by
multiplying the number of predicted cases by the variable
cost. Third, to determine overall savings, the observed
level of each of the three variables in Equation 1 was subtracted from the estimated level. The determination of
savings for each variable will be discussed in detail below.
To determine PETsaved, the first step was to predict the
number of cases that would have existed in the absence
of the OMNR ORV programme (Fig. 1). To do this, we
used four different forecasting techniques including a
simple Box-Jenkins autoregressive (AR 1) model, a quadratic (QUAD) and two different linear regression (LINEAR 1 and LINEAR 2) estimates. For the LINEAR 1
estimate, we fit a linear regression to the pre-ORV period
(£1989) and then forecasted that trend into the postORV period (1990–2000). For the LINEAR 2 estimate, we
again fit a linear regression however this estimate omitted
the peak in the data at 1986, which makes the slope of
LINEAR 1 > LINEAR 2. The linear fit in the pre-ORV
period suggests that on average the annual number of fox
rabies related PET cases were increasing each year. We
assumed that this fit in the post-ORV period indicates
the number of cases that would have occurred if the ORV
programme had never existed.
^
The difference between the predicted (PETy )and actual
y
(PETactual )PETs represents the savings resulting from the
ORV programme. Therefore,
y

^

y

PETsaved ¼ ðPETy  PETactual ÞPETcosts :

ð2Þ

We estimated PETcost from correspondence with personnel involved in providing the vaccine. Values for a
single PET varied between $2500 in Pennsylvania (MacInnes et al., 2001) and $1500–2500 USD ($1770–$2950
CAD) for the entire United States (C. Rupprecht, personal communication). Shwiff et al. (2007) determined
that PET (PEP) costs were $2540 USD or approximately
$3000 CAD in 2006 dollars. In Canada, as of January
2004, the cost of the biologics used in rabies PET was
approximately $1021 ($1108 2006 CAD) (D. Middleton,
personal communication). We felt that a value between
the United States and the Canadian estimates more closely represented the actual amount paid for PET in
Ontario, and we used an estimate of $1750 in 2006 CAD.
In addition to direct cost of a rabid animal exposure,
indirect costs should be considered. Although the direct
costs include the vaccine and other biologics, indirect
costs refer to things like over-the-counter medicines,
ª 2010 Blackwell Verlag GmbH • Zoonoses Public Health. 58 (2011) 169–177
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Fig. 3. Amount paid out from the rabies indemnification programme in Canada versus the amount predicted in the absence of oral rabies vaccine baiting (1978–2000).

travel to physicians and lost time from work associated
with treatment. Indirect costs have been estimated to
compose approximately one-third of the TC associated
with a rabid animal exposure (Shwiff et al., 2007). However, only direct costs were included.
The calculation of savings related to AT were similar
to PET. The number of positive animals represents only
a fraction of the costs that were incurred to test animals
suspected of having rabies. The number of animals that
tested negative for rabies was not available for this
study, so the approximate total number of animals
tested had to be derived. A study by Shwiff et al. (2007)
found that over a 10-year period (1991–2000) in California approximately 1 in every 5.27 skunks tested were
rabies positive. Extrapolating this proportion to Canada
was most likely conservative because in some years during the 1980s at the height of the rabies enzootic,
15 000 to 25 000 rabies investigations involving public
health officials were carried out annually (Nunan et al.,
2002). The cost information for testing animals for
rabies was based upon indications from the Ontario
Ministry of Health that placed the costs at $650 per test.
This value was consistent with the findings of the Shwiff
et al.’s (2007) study.
Calculation of the ATsavings portion of Equation 1
involves an equation similar to Equation 2, with the
exception that animals testing negative must be included.
This calculation was accomplished through a scalar (5.27
as mentioned above), producing an estimate of the total
number of animals tested (Fig. 2). Therefore,
ª 2010 Blackwell Verlag GmbH • Zoonoses Public Health. 58 (2011) 169–177

^

y

y

ATsaved ¼ ½ðATy  ATactual Þ  5:27ATcosts

ð3Þ

represents the savings associated with the reduction in the
total number of animals tested for rabies.
Indemnity payments were the last portion of the benefits equation included. These payments began in 1979,
reached a peak in 1987 and then slowly declined after
1995, likely because of the initiation of the OMNR ORV
programme in 1989. As with the PET and AT, it was necessary to predict the number of cases (or payment volume) that would have existed in the absence of the ORV
programme (Fig. 3). The pre-intervention data for
INDEM were limited, making the use of standard time
series techniques problematic. This caused a modification
of the some of the four forecasting techniques used
including, a naive forecasting method which simply
repeated the data set over the forecast range (REPEAT 1)
instead of an AR 1 model and the linear regression of
REPEAT 1 as the estimate for LINEAR 2. The QUAD and
LINEAR 1 estimates were conducted using the same
methodology as in PET and AT.
The methods described above were employed to make
the projections, with the exception of the cost variable.
The equation used to calculate indemnity was:
y

^

y

INDEMsaved ¼ ðINDEMy  INDEMactual Þ:

ð4Þ

Estimation of all three of the components of Equation 1 permits the determination of TB.
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The estimation of TB over the entire period since the
initiation of the ORV programme can be written by
substituting Equations 2–4 in Equation 1:
TB ¼

2000
X

^

y

^

in current dollars, there was a statistical difference at
the 10% level in the pre- ($246 809 ± $26 887) and
post-ORV ($145 327 ± $41 836) periods (P = 0.0547).
y

^

y

fðPETy  PETactual ÞPETcosts þ ½ðATy  ATactual Þ5:27ATcosts þ ðINDEMy  INDEMactual Þg

ð5Þ

y¼1989

All estimates of costs and indemnity payments are
given in 2006 dollars.
The cost composition was determined from the total
expenditures on the OMNR ORV programme from 1989
to 2000. Total costs were divided into three major categories: rabies unit costs, contract costs and bait machinery
costs. The largest portion of costs during the ORV programme was under the category of contract costs for bait
manufacture, which made up roughly 38% of the TC.
Total costs for the time period relevant for this study
(1989–2000) were $77 372 637 in 2006 CAD (Table 1).
This was the value included in the analysis to determine
the overall efficiency of the OMNR ORV programme.
The benefit-cost ratios (BCRs) were calculated using
the standard format of the ratio of benefits to costs (Loomis, 1993; Zerbe and Dively, 1994; Boardman et al.,
1996; Nas, 1996; Loomis and Walsh, 1997). The basic
BCR was calculated from the equation:
Benefits
Costs
$ value of PET, AT and indemnity costs saved
ð6Þ
¼
$ cost of ORV baiting

BCR ¼

A BCR of 1.0 would indicate that the benefits and costs
were equal, or in other words, 1 unit of costs yields 1 unit
of benefits. A BCR greater than 1.0 would indicate that the
benefits of the ORV programme outweigh the costs, and
that the monies allocated to the project were economically
efficient. Often, it is the case for multi-year projects that
the best determination of efficiency is over the entire lifetime of the project rather than over a single year.
Results
The results for the anova confirm expectations regarding the initiation of the ORV programme in 1989. The
results (mean ± SE) indicate that for human PET there
was a statistical difference at the 5% level in the pre(2248 ± 258) and post-ORV (1468 ± 173) periods
(P = 0.0207) (Fig. S1). The results for AT indicate that
at the 1% level, there was a difference in the pre(1861 ± 164) and post-ORV (637 ± 182) periods
(P = 0.0001) (Fig. S1). Finally, for indemnity payments,
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These results confirm that in comparison to the preORV period, the post-ORV period saw lower rates of
human PET, AT and indemnity payments on average
(Fig. S2). The results of the BCA will determine if this
reduction produces enough savings to justify the costs
and establish economic efficiency for the whole ORV
programme.
Benefits were estimated using four different forecasting
techniques, including a simple Box-Jenkins autoregressive
(a repeat model for INDEM), a quadratic and two different linear regressions, and are presented in Table 2. These
estimated benefits were calculated over the study period
and range from $35 486 316 to $98 413 217. The per cent
of the total that PET, AT and INDEM savings represent
vary depending upon the forecasting method used. For all
methods, INDEM made up a minor amount of the total
savings (£5%). For the AR 1/Repeat method, PET made
up the majority of the TB whereas for all of the other
methods benefits associated with reduced AT costs were
the largest component of the total.
We calculated the BCRs by summing the savings to
PET, AT and INDEM resulting from the initiation of the
OMNR ORV programme and comparing them to the
annual costs (Table 3). Overall programme economic efficiency (BCR > 1.0) was achieved in three of the four
forecasting estimates. The only forecasting methodology
that did not yield economic efficiency was the AR1 estimate which was also the most conservative. This was not
surprising because this estimation methodology weights
the most recent observations higher than past observations meaning that the upward trend in the data until
1986 was weighted less than the downward trend from
1987 to 1989, which gave an overall downward trend to
the predicted future values from 1990 to 2000 (Enders,
1995).
In the early years of baiting, under the Linear 1, 2 and
Quadratic estimates the BCRs in 1990–1992 (1993 for
Linear 2) were less than 1.0 (although increasing), meaning that the benefits experienced through savings, were
not large enough to justify baiting in those years. Because
of the lag time of the PET savings, the true savings were
not seen until later years, as represented by BCRs greater
than 1.0 from 1993 to 2000. For example, the BCRs
under these three scenarios peaked in 1998 at greater than
2, when the benefits to society were over twice the cost of
the OMNR ORV programme. The overall BCRs, since the
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Table 2. Benefits of the Ontario oral rabies vaccination programme in 2006 CAD (1990–2000)
PET

AT

INDEM

Forecasting Method

Benefits

% of total

Benefits

% of total

Benefits

AR 1/Repeat
Linear 1
Linear 2
Quadratic

$33 076 217
$25 602,933
$14 920 880
$45 943 491

93
26
19
47

$1 173 970
$67 065 367
$60 729 267
$50 365 786

3
68
79
51

$1
$5
$1
$2

Table 3. Benefit-cost ratios for Ontario oral rabies vaccination programme (1990–2000)
BCRs
Year

AR 1/Repeat

Linear 1

Linear 2

Quadratic

1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
Average

)0.04
0.09
)0.05
)0.28
0.64
0.75
0.96
0.97
1.13
1.05
0.71
0.49

0.22
0.55
0.88
1.05
1.74
1.70
1.93
1.96
2.40
2.32
1.73
1.27

0.11
0.38
0.54
0.59
1.38
1.40
1.61
1.64
2.01
1.94
1.43
1.06

0.23
0.57
0.91
1.08
1.76
1.72
1.94
1.97
2.42
2.33
1.74
1.36

ORV Programme’s inception, under the Linear 1, 2 and
Quadratic scenarios were 1.06, 1.27 and 1.36, respectively.
This can be interpreted as, for every dollar spent, between
$1.06 and $1.36 in savings was realized. The results of the
BCA indicate that programme efficiency was gained under
the assumptions made in the analysis. Many of the
assumptions in this analysis lend to these results being
conservative.
The results from the AR1 estimates indicate that in all
years except 1998 and 1999, programme efficiency was
not achieved. The AR1 process was not used to forecast
INDEM because of data limitations so the data were simply repeated in the future. Given the nature of the AR1
forecast, the lowest savings were garnered under this scenario for both PET and AT, especially in the initial years
of baiting. The downward estimation of the AR1 estimate
suppressed potential savings resulting from the ORV programme decreasing the number of PET and AT administered, which created a situation in which the costs
exceeded the benefits for this scenario.
Discussion
The choice of forecasting technique clearly played a role
in the determination of overall programme efficiency.
ª 2010 Blackwell Verlag GmbH • Zoonoses Public Health. 58 (2011) 169–177

236
240
329
103

129
224
842
940

% of total

Total programme benefits

3
5
2
2

$35
$97
$76
$98

486
908
979
413

316
524
988
217

Three of the four forecasting techniques indicated an
upward trend to the data. The AR1 process, however,
indicated an overall decrease in the number of future
cases given the most recent trends in the data, which,
contrary to the other techniques, does not equally weight
all of the observations, instead more weight is given to
the most recent observations. The two linear regressions
and the quadratic estimates indicated that the OMNR
ORV programme was successful, based on the reductions
in PETs, AT and INDEM (Hauschildt et al., 2001; MacInnes et al., 2001; Nunan et al., 2002). Additionally, based
on assumptions, results show that the OMNR ORV programme was cost efficient under these three estimates,
which yielded an overall programme BCR greater than 1.
As expected, the first 2 years of the study were not cost
effective, because bait distribution techniques were still
being developed and only a portion of the rabies endemic
areas were baited. Obviously, removing the two initial
years from the analysis would increase the overall BCRs
and would result in greater programme efficiency. The
results of these three scenarios confirm the cost effectiveness of a limited regional use of an ORV strategy involving canids. Although MacInnes et al. (2001) reported
success of this strategy to eliminate arctic-fox-(Alopex lagopus)-variant rabies from red fox vectors in southern
Ontario Province, Canada, they provided no economic
data for their programme. But, economics can often be
the basis for the justification and the rationale of such
programmes.
Each forecasting method is not intended to suggest
that these trends will continue ad infinitum, but rather
over the short-term to 2000. Additionally, no suggestion
is made regarding which technique provides the ‘best’
fit for forecasting the data. All forecasting techniques
have limitations. Therefore, multiple estimations of
future potential trends in the data were projected to
provide an array of possible future scenarios to minimize the uncertainty surrounding the projection of
overall results.
It has been argued that disease epizootics are cyclical in
that a population of sick animals increases for a period of
time and then dissipates as die off occurs (MacInnes et
al., 2001). Upon examining this data set, cyclical trends
175
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appear in the PET and INDEM data but were not present
in the data for AT. For PET, the cycle was approximately
every 19–20 years, whereas for INDEM every 5–6 years.
Interestingly, in both cases (PET and INDEM), the overall
average of the number of animals involved in a ‘cycle’
was increasing suggesting that overtime each ‘cycle’
involves more animals, which was consistent with the
three upward trending forecasts and inconsistent with the
AR1 forecast.
The inclusion of more comprehensive rabies-caused
cost impacts (i.e. pet vaccinations, livestock vaccinations,
rabies educational programmes, human deaths, pet
replacements, etc.) as sources of potential benefits would
undoubtedly have increased the projected OMNR ORV
programme benefits substantially. For example, Uhaa et
al. (1992) reported 20% increased pet vaccinations
occurred in the New Jersey epizootic of raccoon rabies
as ‘once-negligent’ pet owners rushed to protect their
pets from the disease outbreak. Intangible benefits also
exist as a result of the OMNR ORV programme, but
were difficult to quantify monetarily. These benefits
include increased quality of life for the residents of the
baited areas. There is a certain level of perceived risk of
infection experienced by individuals living in a rabies
epizootic region. Actual probability of death resulting
from infection by the fox variant of rabies may be low;
however, if perceptions of risk is high, individuals
receive a benefit from a perceived reduction in the probability that they will be infected with rabies. The recognition of all benefits when a government action is
undertaken is vital to determining the total value, but
cannot necessarily be included in the monetary calculations. Pet and livestock vaccinations, potential loss of
human life and intangible benefits were outside the
scope of this study and as a result, these potential benefits were excluded. The omission of these costs decreased
the total estimated benefits, potentially making the BCRs
more conservative.
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